Skip to main content
Veterinary Medicines

Damtix 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg

Authorised
  • Imidacloprid
  • Permethrin (40:60)

Product identification

Medicine name:
Damtix 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg
Damtix 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg
Active substance:
  • Imidacloprid
  • Permethrin (40:60)
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Imidacloprid
    100.00
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin (40:60)
    500.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1.0 ml of solution Box containing 10 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1.0 ml of solution Box containing 6 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1.0 ml of solution Box containing 4 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1.0 ml of solution Box containing 3 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1.0 ml of solution Box containing 1 pipette

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10774/073/002
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0663/002
Concerned member states:
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 6/07/2025
Download

Combined File of all Documents

English (PDF)
Published on: 6/07/2025
Download